Jefferies Financial Group’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.7M Buy
168,705
+163,934
+3,436% +$19.8M 0.12% 139
2026
Q2
$636K Sell
4,771
-5,382
-53% -$609K ﹤0.01% 1168
2026
Q1
$1.13M Sell
10,153
-447,172
-98% -$52.9M 0.01% 879
2025
Q4
$61.7M Hold
457,325
– – 0.32% 52
2025
Q3
$38.8M Buy
+457,325
New +$28M 0.18% 79

Other funds holding ABVX

Jefferies Financial Group's ABVX Position: Q3 2026 in Review

Jefferies Financial Group increased its Abivax (ABVX) stake by 3,436% in Q3 2026, buying an estimated $19.8M and bringing the position to 168,705 shares worth $16.7M. The position accounts for 0.12% of the portfolio, ranked #139.

Jefferies Financial Group first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $61.7M in Q4 2025. 124 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Jefferies Financial Group held 168,705 shares of Abivax worth $16.7M as of Q3 2026.
  • Jefferies Financial Group bought 163,934 Abivax shares in Q3 2026, an estimated $19.8M.
  • Abivax made up 0.12% of Jefferies Financial Group's portfolio in Q3 2026, its #139 holding.
  • Jefferies Financial Group first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
  • Jefferies Financial Group's Abivax position peaked at $61.7M in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.